Chimeric Therapeutics Limited (ASX:CHM)
Australia
· Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
Mar 10, 2026, 4:10 PM AEST
Chimeric Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Net Income | -18.79 | -10.43 | -12.53 | -25.92 | -15.9 | -15.11 | Upgrade
|
| Depreciation & Amortization | 1.52 | 1.03 | 1.08 | 0.97 | 0.95 | 0.85 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | 0.01 | 0 | 0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.09 | -0.09 | 1.26 | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.09 | 1.09 | 0.89 | 3.32 | 3.17 | 2.1 | Upgrade
|
| Other Operating Activities | 6.06 | -0.6 | 0.15 | 1.47 | 0.84 | 1 | Upgrade
|
| Change in Accounts Receivable | -0.01 | -0.01 | 3.56 | -0.99 | -2.63 | -0.02 | Upgrade
|
| Change in Accounts Payable | 1.94 | 1.94 | -1.98 | 4.74 | 0.32 | 2.59 | Upgrade
|
| Change in Other Net Operating Assets | -0.2 | -0.2 | 0.01 | 0.1 | 0.1 | -0.23 | Upgrade
|
| Operating Cash Flow | -8.49 | -7.28 | -7.54 | -16.31 | -13.15 | -8.83 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.01 | -0.02 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.11 | -0.53 | -5.29 | Upgrade
|
| Investment in Securities | - | - | - | - | -0.04 | - | Upgrade
|
| Investing Cash Flow | -0.24 | - | - | -0.11 | -0.58 | -5.31 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.86 | Upgrade
|
| Total Debt Issued | -1.56 | - | - | - | - | 0.86 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.89 | Upgrade
|
| Long-Term Debt Repaid | - | - | -2.28 | -2.23 | -4.05 | - | Upgrade
|
| Total Debt Repaid | -2.54 | - | -2.28 | -2.23 | -4.05 | -0.89 | Upgrade
|
| Net Debt Issued (Repaid) | -4.1 | - | -2.28 | -2.23 | -4.05 | -0.03 | Upgrade
|
| Issuance of Common Stock | 9 | 8.2 | 11.74 | 2.58 | 14.9 | 39.3 | Upgrade
|
| Other Financing Activities | 1.39 | 1.84 | -1.21 | -0.1 | -1.31 | -2.72 | Upgrade
|
| Financing Cash Flow | 6.28 | 10.05 | 8.26 | 0.25 | 9.54 | 36.54 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.11 | -0.07 | -0.03 | 0.15 | 0.16 | 0.01 | Upgrade
|
| Net Cash Flow | -2.56 | 2.7 | 0.69 | -16.02 | -4.03 | 22.41 | Upgrade
|
| Free Cash Flow | -8.49 | -7.28 | -7.54 | -16.31 | -13.17 | -8.85 | Upgrade
|
| Free Cash Flow Margin | -87.11% | -57.36% | -101.07% | -361.89% | -503.04% | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.04 | -0.04 | -0.05 | Upgrade
|
| Cash Interest Paid | 0.05 | - | 0.01 | 0.01 | - | 0.01 | Upgrade
|
| Cash Income Tax Paid | - | -4.17 | -7.34 | -3.5 | - | - | Upgrade
|
| Levered Free Cash Flow | -4.59 | -2.15 | -3.7 | -10.45 | -6.8 | -4.57 | Upgrade
|
| Unlevered Free Cash Flow | -4.4 | -2.02 | -3.49 | -9.97 | -6.4 | -4.57 | Upgrade
|
| Change in Working Capital | 1.73 | 1.73 | 1.6 | 3.85 | -2.21 | 2.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.